Eric E. Poma, Chief Executive Officer at Calidi Biotherapeutics, Inc. (CLDI), bought 25,000 shares at $2.00 ($50K) on 2025-08-21, disclosed to the SEC on 2025-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.